Allakos Inc
NASDAQ:ALLK
Allakos Inc
NASDAQ:ALLK
Price:
1.16 USD
5.45%
Market Closed
Updated:
May 4, 2024
Allakos Inc
Cash from Investing Activities
|
Allakos Inc
Cash from Investing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Allakos Inc
NASDAQ:ALLK
|
Cash from Investing Activities
$93.2m
|
CAGR 3-Years
188%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-76%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$26.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$3.2B
|
CAGR 3-Years
-256%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-25%
|
See Also
What is Allakos Inc's Cash from Investing Activities?
Cash from Investing Activities
93.2m
USD
93.2m
USD
Based on the financial report for Dec 31, 2023, Allakos Inc's Cash from Investing Activities amounts to 93.2m USD.
What is Allakos Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
188%
188%
Over the last year, the Cash from Investing Activities growth was 30%. The average annual Cash from Investing Activities growth rates for Allakos Inc have been 188% over the past three years .
You don't have any saved screeners yet
